메뉴 건너뛰기




Volumn 53, Issue 7, 1999, Pages 434-435

Evaluation of the impact of Dublin's expanded harm reduction programme on prevalence of hepatitis C among short-term injecting drug users

Author keywords

[No Author keywords available]

Indexed keywords

DIAMORPHINE; HEPATITIS C ANTIBODY; MORPHINE;

EID: 0033019581     PISSN: 0143005X     EISSN: None     Source Type: Journal    
DOI: 10.1136/jech.53.7.434     Document Type: Article
Times cited : (21)

References (5)
  • 1
    • 0029867968 scopus 로고    scopus 로고
    • Viral infections in short-term injection drug users: The prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphocyte viruses
    • Garfein RS, Vlahov D, Galia N, et al. Viral infections in short-term injection drug users: The prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphocyte viruses. Am J Public Health 1996;86:655-61.
    • (1996) Am J Public Health , vol.86 , pp. 655-661
    • Garfein, R.S.1    Vlahov, D.2    Galia, N.3
  • 2
    • 0028168167 scopus 로고
    • Deaths, HIV infection, abstinence, and other outcomes in a cohort of injecting drug users followed up for 10 years
    • Robertson JR, Ronald PJM, Raab GM, et al. Deaths, HIV infection, abstinence, and other outcomes in a cohort of injecting drug users followed up for 10 years. BMJ 1994;309:369-72.
    • (1994) BMJ , vol.309 , pp. 369-372
    • Robertson, J.R.1    Ronald, P.J.M.2    Raab, G.M.3
  • 3
    • 0028936895 scopus 로고
    • Changes in the injecting risk behaviour of injecting drug users in London 1990-1993
    • Hunter GM, Donoghoe MC, Stimson GV, et al. Changes in the injecting risk behaviour of injecting drug users in London 1990-1993. AIDS 1995;9:493-501.
    • (1995) AIDS , vol.9 , pp. 493-501
    • Hunter, G.M.1    Donoghoe, M.C.2    Stimson, G.V.3
  • 4
    • 0028846040 scopus 로고
    • Reduced risk of hepatitis B and hepatitis C among injection drug users in the Tacoma syringe exchange program
    • Hagan H, Des Jarlais DC, Friedman SR, et al. Reduced risk of hepatitis B and hepatitis C among injection drug users in the Tacoma syringe exchange program. Am J Public Health 1995;85:1531-7.
    • (1995) Am J Public Health , vol.85 , pp. 1531-1537
    • Hagan, H.1    Des Jarlais, D.C.2    Friedman, S.R.3
  • 5
    • 0030074297 scopus 로고    scopus 로고
    • Once more unto the breach: Controlling hepatitis C in injecting drug users
    • Wodak A, Crofts N. Once more unto the breach: controlling hepatitis C in injecting drug users. Addiction 1996;91:181-4.
    • (1996) Addiction , vol.91 , pp. 181-184
    • Wodak, A.1    Crofts, N.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.